InflaRx NV (STU:IF0) Net Margin %: 0.00% (As of Mar. 2026)


STU:IF0 InflaRx NV STU:IF0
30 GF Score
Price €1.68
! 5 Warning Signs
View Full Analysis

What is InflaRx NV Net Margin %?

InflaRx NV STU:IF0 +0.72% 30 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates STU:IF0 with a GF Score™ of 30/100. The stock has 5 warning signs investors should review. Among 947 Biotechnology companies, InflaRx NV ranks worse than 98.31% on this metric.

Net margin is calculated as Net Income divided by its Revenue. InflaRx NV's Net Income for the three months ended in Mar. 2026 was €-5.59 Mil. InflaRx NV's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, InflaRx NV's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for InflaRx NV's Net Margin % or its related term are showing as below:

STU:IF0' s Net Margin % Range Over the Past 10 Years
Min: -157164.71   Med: -67434.78   Max: -27721.26
Current: -151348.49

STU:IF0's Net Margin % is ranked worse than
98.31% of 947 companies
in the Biotechnology industry
Industry Median: -89.56 vs STU:IF0: -151348.49

InflaRx NV  (STU:IF0) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

InflaRx NV Net Margin % Related Terms

InflaRx NV Net Margin % Historical Data

* Premium members only.

The historical data trend for InflaRx NV's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InflaRx NV Net Margin % Chart

InflaRx NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -67,726.98 -27,749.40 -157,358.62

InflaRx NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -36,964.10 -51,087.50 31,300.00 0.00

STU:IF0 vs IRD, NAUT, RGNX: Net Margin % Comparison

For the Biotechnology subindustry, InflaRx NV's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InflaRx NV Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InflaRx NV's Net Margin % distribution charts can be found below:

* The bar in red indicates where InflaRx NV's Net Margin % falls into.


STU:IF0
30GF Score
InflaRx NV STU:IF0
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InflaRx NV Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

InflaRx NV's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-45.634/0.029
=-157,358.62 %

InflaRx NV's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-5.593/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
InflaRx NV (STU:IF0) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on InflaRx NV and its competitors. According to the industry distribution chart, InflaRx NV ranks #931 out of 947 companies in the Biotechnology industry, placing it in the top 98.3%.
Is InflaRx NV's Net Margin % too high?
InflaRx NV's current Net Margin % is 0.00%. Based on the distribution chart, InflaRx NV ranks #931 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, InflaRx NV has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does InflaRx NV's Net Margin % compare to IRD and NAUT?
According to the Biotechnology industry distribution chart, InflaRx NV ranks #931 out of 947 companies for Net Margin %. This places InflaRx NV in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on InflaRx NV and its competitors. InflaRx NV's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InflaRx NV stock overvalued right now?
InflaRx NV (STU:IF0) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. InflaRx NV's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For InflaRx NV (STU:IF0), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

InflaRx NV Business Description

Other Exchanges IFRX:USAIF0:Germany
Address Winzerlaer Strasse 2, Jena, DEU, 07745
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
30GF Score

Get the complete analysis for STU:IF0

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.68
Price